You are here

  • Home
  • Archive
  • Volume 11, Issue 9
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

Article info

Article menu
Basic tumor immunology
Original research
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

Authors

  • Zaki Molvi Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Martin G Klatt Department of Hematology, Oncology and Tumor Immunology, Charite Universitatsmedizin Berlin, Berlin, GermanyGerman Cancer Research Center, Heidelberg, Baden-Württemberg, GermanyBerlin Institute of Health at Charité –Universitätsmedizin Berlin, BIH Biomedical 13 Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany PubMed articlesGoogle scholar articles
  • Tao Dao Department of Pediatrics, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jessica Urraca Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • David A Scheinberg Department of Pediatrics, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USAWeill Cornell Medicine, New York, New York, USA PubMed articlesGoogle scholar articles
  • Richard J O'Reilly Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USADepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articlesGoogle scholar articles

Citation

Molvi Z, Klatt MG, Dao T, et al
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
Journal for ImmunoTherapy of Cancer 2023;11:e006889. doi: 10.1136/jitc-2023-006889
Online issue publication 
December 06, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.